Colgate-Palmolive (NYSE:CL) Shares Acquired by Boston Common Asset Management LLC

Boston Common Asset Management LLC grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 53.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 268,448 shares of the company's stock after acquiring an additional 93,121 shares during the period. Boston Common Asset Management LLC's holdings in Colgate-Palmolive were worth $24,405,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp boosted its position in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after buying an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after buying an additional 557,492 shares during the period. Legal & General Group Plc increased its holdings in Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after buying an additional 61,413 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.37% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of CL stock traded up $0.23 on Friday, reaching $88.79. 5,149,874 shares of the stock were exchanged, compared to its average volume of 3,679,883. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The stock has a market cap of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a 50 day moving average of $92.20 and a two-hundred day moving average of $97.74.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CL. StockNews.com downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Finally, Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a report on Friday. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.